nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—Metipranolol—glaucoma	0.238	0.588	CrCtD
Acebutolol—Betaxolol—glaucoma	0.166	0.412	CrCtD
Acebutolol—ADRB2—Metipranolol—glaucoma	0.0262	0.1	CbGbCtD
Acebutolol—ADRB2—Levobunolol—glaucoma	0.0262	0.1	CbGbCtD
Acebutolol—ADRB1—Levobunolol—glaucoma	0.0258	0.0988	CbGbCtD
Acebutolol—ADRB1—Metipranolol—glaucoma	0.0258	0.0988	CbGbCtD
Acebutolol—ADRB2—Carteolol—glaucoma	0.0222	0.0853	CbGbCtD
Acebutolol—ADRB1—Carteolol—glaucoma	0.0219	0.084	CbGbCtD
Acebutolol—SLC22A1—Latanoprost—glaucoma	0.0193	0.0741	CbGbCtD
Acebutolol—Metoprolol—Metipranolol—glaucoma	0.0166	0.0621	CrCrCtD
Acebutolol—Oxprenolol—Metipranolol—glaucoma	0.0166	0.0621	CrCrCtD
Acebutolol—Practolol—Metipranolol—glaucoma	0.0166	0.0621	CrCrCtD
Acebutolol—Alprenolol—Metipranolol—glaucoma	0.0166	0.0621	CrCrCtD
Acebutolol—ADRB2—Dipivefrin—glaucoma	0.0159	0.0608	CbGbCtD
Acebutolol—Atenolol—Metipranolol—glaucoma	0.0157	0.0588	CrCrCtD
Acebutolol—ADRB2—Betaxolol—glaucoma	0.015	0.0576	CbGbCtD
Acebutolol—Esmolol—Metipranolol—glaucoma	0.0149	0.0558	CrCrCtD
Acebutolol—Pindolol—Carteolol—glaucoma	0.0149	0.0558	CrCrCtD
Acebutolol—Pindolol—Levobunolol—glaucoma	0.0149	0.0558	CrCrCtD
Acebutolol—ADRB1—Betaxolol—glaucoma	0.0148	0.0567	CbGbCtD
Acebutolol—Pindolol—Metipranolol—glaucoma	0.0142	0.0532	CrCrCtD
Acebutolol—Bisoprolol—Betaxolol—glaucoma	0.0131	0.0492	CrCrCtD
Acebutolol—Alprenolol—Betaxolol—glaucoma	0.0116	0.0435	CrCrCtD
Acebutolol—Oxprenolol—Betaxolol—glaucoma	0.0116	0.0435	CrCrCtD
Acebutolol—Metoprolol—Betaxolol—glaucoma	0.0116	0.0435	CrCrCtD
Acebutolol—Practolol—Betaxolol—glaucoma	0.0116	0.0435	CrCrCtD
Acebutolol—Atenolol—Betaxolol—glaucoma	0.011	0.0411	CrCrCtD
Acebutolol—Esmolol—Betaxolol—glaucoma	0.0104	0.0391	CrCrCtD
Acebutolol—Pindolol—Betaxolol—glaucoma	0.00991	0.0372	CrCrCtD
Acebutolol—Propranolol—Carteolol—glaucoma	0.00969	0.0364	CrCrCtD
Acebutolol—Propranolol—Levobunolol—glaucoma	0.00969	0.0364	CrCrCtD
Acebutolol—ADRB2—Timolol—glaucoma	0.00968	0.0371	CbGbCtD
Acebutolol—ADRB1—Timolol—glaucoma	0.00954	0.0366	CbGbCtD
Acebutolol—Propranolol—Metipranolol—glaucoma	0.00924	0.0347	CrCrCtD
Acebutolol—SLC22A1—Clonidine—glaucoma	0.00715	0.0274	CbGbCtD
Acebutolol—Propranolol—Betaxolol—glaucoma	0.00647	0.0243	CrCrCtD
Acebutolol—CYP2D6—Carteolol—glaucoma	0.00558	0.0214	CbGbCtD
Acebutolol—CYP2D6—Betaxolol—glaucoma	0.00377	0.0144	CbGbCtD
Acebutolol—CYP2D6—Methazolamide—glaucoma	0.00286	0.0109	CbGbCtD
Acebutolol—ABCB1—Timolol—glaucoma	0.00258	0.00988	CbGbCtD
Acebutolol—CYP2D6—Timolol—glaucoma	0.00243	0.00931	CbGbCtD
Acebutolol—ABCB1—Clonidine—glaucoma	0.00219	0.0084	CbGbCtD
Acebutolol—CYP2D6—Clonidine—glaucoma	0.00206	0.00792	CbGbCtD
Acebutolol—ADRB2—Treprostinil—Latanoprost—glaucoma	0.000742	1	CbGdCrCtD
Acebutolol—Erectile dysfunction—Timolol—glaucoma	4.31e-05	0.000639	CcSEcCtD
Acebutolol—Urticaria—Acetazolamide—glaucoma	4.3e-05	0.000638	CcSEcCtD
Acebutolol—Dyspepsia—Brinzolamide—glaucoma	4.29e-05	0.000637	CcSEcCtD
Acebutolol—Pruritus—Apraclonidine—glaucoma	4.28e-05	0.000635	CcSEcCtD
Acebutolol—Body temperature increased—Acetazolamide—glaucoma	4.28e-05	0.000634	CcSEcCtD
Acebutolol—Fatigue—Dorzolamide—glaucoma	4.28e-05	0.000634	CcSEcCtD
Acebutolol—Tinnitus—Betaxolol—glaucoma	4.28e-05	0.000634	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Pilocarpine—glaucoma	4.27e-05	0.000633	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Travoprost—glaucoma	4.26e-05	0.000632	CcSEcCtD
Acebutolol—Fatigue—Travoprost—glaucoma	4.26e-05	0.000631	CcSEcCtD
Acebutolol—Flushing—Betaxolol—glaucoma	4.26e-05	0.000631	CcSEcCtD
Acebutolol—Ill-defined disorder—Clonidine—glaucoma	4.25e-05	0.000631	CcSEcCtD
Acebutolol—Pain—Dorzolamide—glaucoma	4.24e-05	0.000629	CcSEcCtD
Acebutolol—Insomnia—Pilocarpine—glaucoma	4.24e-05	0.000629	CcSEcCtD
Acebutolol—Decreased appetite—Brinzolamide—glaucoma	4.24e-05	0.000629	CcSEcCtD
Acebutolol—Pain—Travoprost—glaucoma	4.22e-05	0.000626	CcSEcCtD
Acebutolol—Constipation—Travoprost—glaucoma	4.22e-05	0.000626	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Brinzolamide—glaucoma	4.21e-05	0.000624	CcSEcCtD
Acebutolol—Paraesthesia—Pilocarpine—glaucoma	4.21e-05	0.000624	CcSEcCtD
Acebutolol—Asthenia—Bimatoprost—glaucoma	4.21e-05	0.000624	CcSEcCtD
Acebutolol—Fatigue—Brinzolamide—glaucoma	4.2e-05	0.000624	CcSEcCtD
Acebutolol—Dyspnoea—Pilocarpine—glaucoma	4.18e-05	0.00062	CcSEcCtD
Acebutolol—Pain—Brinzolamide—glaucoma	4.17e-05	0.000618	CcSEcCtD
Acebutolol—Somnolence—Pilocarpine—glaucoma	4.17e-05	0.000618	CcSEcCtD
Acebutolol—Depression—Timolol—glaucoma	4.16e-05	0.000617	CcSEcCtD
Acebutolol—Angiopathy—Betaxolol—glaucoma	4.16e-05	0.000617	CcSEcCtD
Acebutolol—Pruritus—Bimatoprost—glaucoma	4.15e-05	0.000615	CcSEcCtD
Acebutolol—Diarrhoea—Apraclonidine—glaucoma	4.14e-05	0.000614	CcSEcCtD
Acebutolol—Malaise—Clonidine—glaucoma	4.14e-05	0.000613	CcSEcCtD
Acebutolol—Mediastinal disorder—Betaxolol—glaucoma	4.13e-05	0.000613	CcSEcCtD
Acebutolol—Dyspepsia—Pilocarpine—glaucoma	4.13e-05	0.000612	CcSEcCtD
Acebutolol—Chills—Betaxolol—glaucoma	4.11e-05	0.00061	CcSEcCtD
Acebutolol—Syncope—Clonidine—glaucoma	4.11e-05	0.00061	CcSEcCtD
Acebutolol—Feeling abnormal—Dorzolamide—glaucoma	4.09e-05	0.000606	CcSEcCtD
Acebutolol—Decreased appetite—Pilocarpine—glaucoma	4.07e-05	0.000604	CcSEcCtD
Acebutolol—Feeling abnormal—Travoprost—glaucoma	4.07e-05	0.000604	CcSEcCtD
Acebutolol—Conjunctivitis—Timolol—glaucoma	4.06e-05	0.000602	CcSEcCtD
Acebutolol—Gastrointestinal pain—Dorzolamide—glaucoma	4.06e-05	0.000602	CcSEcCtD
Acebutolol—Alopecia—Betaxolol—glaucoma	4.05e-05	0.000601	CcSEcCtD
Acebutolol—Palpitations—Clonidine—glaucoma	4.05e-05	0.000601	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Pilocarpine—glaucoma	4.05e-05	0.0006	CcSEcCtD
Acebutolol—Gastrointestinal pain—Travoprost—glaucoma	4.04e-05	0.000599	CcSEcCtD
Acebutolol—Loss of consciousness—Clonidine—glaucoma	4.03e-05	0.000598	CcSEcCtD
Acebutolol—Feeling abnormal—Brinzolamide—glaucoma	4.02e-05	0.000596	CcSEcCtD
Acebutolol—Pain—Pilocarpine—glaucoma	4.01e-05	0.000594	CcSEcCtD
Acebutolol—Constipation—Pilocarpine—glaucoma	4.01e-05	0.000594	CcSEcCtD
Acebutolol—Cough—Clonidine—glaucoma	4e-05	0.000594	CcSEcCtD
Acebutolol—Sweating—Timolol—glaucoma	4e-05	0.000593	CcSEcCtD
Acebutolol—Dizziness—Apraclonidine—glaucoma	4e-05	0.000593	CcSEcCtD
Acebutolol—Urticaria—Dorzolamide—glaucoma	3.94e-05	0.000584	CcSEcCtD
Acebutolol—Abdominal pain—Dorzolamide—glaucoma	3.92e-05	0.000582	CcSEcCtD
Acebutolol—Body temperature increased—Dorzolamide—glaucoma	3.92e-05	0.000582	CcSEcCtD
Acebutolol—Arthralgia—Clonidine—glaucoma	3.9e-05	0.000579	CcSEcCtD
Acebutolol—Chest pain—Clonidine—glaucoma	3.9e-05	0.000579	CcSEcCtD
Acebutolol—Abdominal pain—Travoprost—glaucoma	3.9e-05	0.000579	CcSEcCtD
Acebutolol—Agranulocytosis—Timolol—glaucoma	3.89e-05	0.000578	CcSEcCtD
Acebutolol—Anxiety—Clonidine—glaucoma	3.89e-05	0.000577	CcSEcCtD
Acebutolol—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	3.89e-05	0.0595	CbGpPWpGaD
Acebutolol—Asthenia—Acetazolamide—glaucoma	3.88e-05	0.000576	CcSEcCtD
Acebutolol—Dizziness—Bimatoprost—glaucoma	3.88e-05	0.000575	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	3.88e-05	0.000575	CcSEcCtD
Acebutolol—Urticaria—Brinzolamide—glaucoma	3.87e-05	0.000575	CcSEcCtD
Acebutolol—Feeling abnormal—Pilocarpine—glaucoma	3.86e-05	0.000573	CcSEcCtD
Acebutolol—Discomfort—Clonidine—glaucoma	3.86e-05	0.000572	CcSEcCtD
Acebutolol—Vomiting—Apraclonidine—glaucoma	3.85e-05	0.00057	CcSEcCtD
Acebutolol—Gastrointestinal pain—Pilocarpine—glaucoma	3.83e-05	0.000568	CcSEcCtD
Acebutolol—Bradycardia—Timolol—glaucoma	3.81e-05	0.000566	CcSEcCtD
Acebutolol—Dermatitis—Apraclonidine—glaucoma	3.81e-05	0.000565	CcSEcCtD
Acebutolol—Headache—Apraclonidine—glaucoma	3.79e-05	0.000562	CcSEcCtD
Acebutolol—Confusional state—Clonidine—glaucoma	3.77e-05	0.00056	CcSEcCtD
Acebutolol—Vision blurred—Betaxolol—glaucoma	3.76e-05	0.000558	CcSEcCtD
Acebutolol—Rhinitis—Timolol—glaucoma	3.76e-05	0.000557	CcSEcCtD
Acebutolol—Oedema—Clonidine—glaucoma	3.74e-05	0.000555	CcSEcCtD
Acebutolol—Hallucination—Timolol—glaucoma	3.73e-05	0.000553	CcSEcCtD
Acebutolol—Asthenia—Brimonidine—glaucoma	3.73e-05	0.000553	CcSEcCtD
Acebutolol—Abdominal pain—Pilocarpine—glaucoma	3.7e-05	0.000549	CcSEcCtD
Acebutolol—Body temperature increased—Pilocarpine—glaucoma	3.7e-05	0.000549	CcSEcCtD
Acebutolol—Ill-defined disorder—Betaxolol—glaucoma	3.7e-05	0.000549	CcSEcCtD
Acebutolol—Diarrhoea—Acetazolamide—glaucoma	3.7e-05	0.000549	CcSEcCtD
Acebutolol—Rash—Bimatoprost—glaucoma	3.7e-05	0.000548	CcSEcCtD
Acebutolol—Dermatitis—Bimatoprost—glaucoma	3.69e-05	0.000548	CcSEcCtD
Acebutolol—Shock—Clonidine—glaucoma	3.68e-05	0.000546	CcSEcCtD
Acebutolol—Connective tissue disorder—Timolol—glaucoma	3.68e-05	0.000546	CcSEcCtD
Acebutolol—Pruritus—Brimonidine—glaucoma	3.67e-05	0.000545	CcSEcCtD
Acebutolol—Headache—Bimatoprost—glaucoma	3.67e-05	0.000545	CcSEcCtD
Acebutolol—Nervous system disorder—Clonidine—glaucoma	3.67e-05	0.000544	CcSEcCtD
Acebutolol—Skin disorder—Clonidine—glaucoma	3.63e-05	0.000539	CcSEcCtD
Acebutolol—Hyperhidrosis—Clonidine—glaucoma	3.62e-05	0.000537	CcSEcCtD
Acebutolol—Visual impairment—Timolol—glaucoma	3.61e-05	0.000536	CcSEcCtD
Acebutolol—Malaise—Betaxolol—glaucoma	3.6e-05	0.000534	CcSEcCtD
Acebutolol—Nausea—Apraclonidine—glaucoma	3.59e-05	0.000533	CcSEcCtD
Acebutolol—Vertigo—Betaxolol—glaucoma	3.59e-05	0.000532	CcSEcCtD
Acebutolol—Syncope—Betaxolol—glaucoma	3.58e-05	0.000531	CcSEcCtD
Acebutolol—Dizziness—Acetazolamide—glaucoma	3.58e-05	0.000531	CcSEcCtD
Acebutolol—Anorexia—Clonidine—glaucoma	3.57e-05	0.000529	CcSEcCtD
Acebutolol—Asthenia—Dorzolamide—glaucoma	3.56e-05	0.000528	CcSEcCtD
Acebutolol—Asthenia—Travoprost—glaucoma	3.54e-05	0.000526	CcSEcCtD
Acebutolol—Palpitations—Betaxolol—glaucoma	3.53e-05	0.000523	CcSEcCtD
Acebutolol—Pruritus—Dorzolamide—glaucoma	3.51e-05	0.00052	CcSEcCtD
Acebutolol—Loss of consciousness—Betaxolol—glaucoma	3.51e-05	0.00052	CcSEcCtD
Acebutolol—Asthenia—Brinzolamide—glaucoma	3.5e-05	0.000519	CcSEcCtD
Acebutolol—Hypotension—Clonidine—glaucoma	3.5e-05	0.000519	CcSEcCtD
Acebutolol—Pruritus—Travoprost—glaucoma	3.49e-05	0.000518	CcSEcCtD
Acebutolol—Tinnitus—Timolol—glaucoma	3.49e-05	0.000518	CcSEcCtD
Acebutolol—Cough—Betaxolol—glaucoma	3.48e-05	0.000517	CcSEcCtD
Acebutolol—Nausea—Bimatoprost—glaucoma	3.48e-05	0.000517	CcSEcCtD
Acebutolol—Pruritus—Brinzolamide—glaucoma	3.45e-05	0.000512	CcSEcCtD
Acebutolol—Vomiting—Acetazolamide—glaucoma	3.44e-05	0.00051	CcSEcCtD
Acebutolol—Dizziness—Brimonidine—glaucoma	3.43e-05	0.000509	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Clonidine—glaucoma	3.41e-05	0.000506	CcSEcCtD
Acebutolol—Angiopathy—Timolol—glaucoma	3.4e-05	0.000504	CcSEcCtD
Acebutolol—Myalgia—Betaxolol—glaucoma	3.4e-05	0.000504	CcSEcCtD
Acebutolol—Arthralgia—Betaxolol—glaucoma	3.4e-05	0.000504	CcSEcCtD
Acebutolol—Chest pain—Betaxolol—glaucoma	3.4e-05	0.000504	CcSEcCtD
Acebutolol—Diarrhoea—Dorzolamide—glaucoma	3.39e-05	0.000503	CcSEcCtD
Acebutolol—Headache—Acetazolamide—glaucoma	3.39e-05	0.000503	CcSEcCtD
Acebutolol—Anxiety—Betaxolol—glaucoma	3.39e-05	0.000502	CcSEcCtD
Acebutolol—Insomnia—Clonidine—glaucoma	3.38e-05	0.000502	CcSEcCtD
Acebutolol—Diarrhoea—Travoprost—glaucoma	3.38e-05	0.000501	CcSEcCtD
Acebutolol—Mediastinal disorder—Timolol—glaucoma	3.38e-05	0.000501	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	3.38e-05	0.000501	CcSEcCtD
Acebutolol—Asthenia—Pilocarpine—glaucoma	3.36e-05	0.000499	CcSEcCtD
Acebutolol—Paraesthesia—Clonidine—glaucoma	3.36e-05	0.000498	CcSEcCtD
Acebutolol—Discomfort—Betaxolol—glaucoma	3.36e-05	0.000498	CcSEcCtD
Acebutolol—Dyspnoea—Clonidine—glaucoma	3.34e-05	0.000495	CcSEcCtD
Acebutolol—Diarrhoea—Brinzolamide—glaucoma	3.34e-05	0.000495	CcSEcCtD
Acebutolol—Somnolence—Clonidine—glaucoma	3.33e-05	0.000493	CcSEcCtD
Acebutolol—Pruritus—Pilocarpine—glaucoma	3.32e-05	0.000492	CcSEcCtD
Acebutolol—Alopecia—Timolol—glaucoma	3.31e-05	0.000491	CcSEcCtD
Acebutolol—Confusional state—Betaxolol—glaucoma	3.29e-05	0.000487	CcSEcCtD
Acebutolol—Dizziness—Dorzolamide—glaucoma	3.28e-05	0.000486	CcSEcCtD
Acebutolol—Rash—Brimonidine—glaucoma	3.27e-05	0.000486	CcSEcCtD
Acebutolol—Dermatitis—Brimonidine—glaucoma	3.27e-05	0.000485	CcSEcCtD
Acebutolol—Dizziness—Travoprost—glaucoma	3.27e-05	0.000484	CcSEcCtD
Acebutolol—Oedema—Betaxolol—glaucoma	3.26e-05	0.000483	CcSEcCtD
Acebutolol—Headache—Brimonidine—glaucoma	3.25e-05	0.000483	CcSEcCtD
Acebutolol—Decreased appetite—Clonidine—glaucoma	3.25e-05	0.000483	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Clonidine—glaucoma	3.23e-05	0.000479	CcSEcCtD
Acebutolol—Fatigue—Clonidine—glaucoma	3.23e-05	0.000479	CcSEcCtD
Acebutolol—Dizziness—Brinzolamide—glaucoma	3.22e-05	0.000478	CcSEcCtD
Acebutolol—Nausea—Acetazolamide—glaucoma	3.21e-05	0.000477	CcSEcCtD
Acebutolol—Diarrhoea—Pilocarpine—glaucoma	3.21e-05	0.000476	CcSEcCtD
Acebutolol—Shock—Betaxolol—glaucoma	3.21e-05	0.000475	CcSEcCtD
Acebutolol—Pain—Clonidine—glaucoma	3.2e-05	0.000475	CcSEcCtD
Acebutolol—Constipation—Clonidine—glaucoma	3.2e-05	0.000475	CcSEcCtD
Acebutolol—Nervous system disorder—Betaxolol—glaucoma	3.2e-05	0.000474	CcSEcCtD
Acebutolol—Skin disorder—Betaxolol—glaucoma	3.16e-05	0.000469	CcSEcCtD
Acebutolol—Vomiting—Dorzolamide—glaucoma	3.15e-05	0.000468	CcSEcCtD
Acebutolol—Hyperhidrosis—Betaxolol—glaucoma	3.15e-05	0.000467	CcSEcCtD
Acebutolol—Rash—Dorzolamide—glaucoma	3.13e-05	0.000464	CcSEcCtD
Acebutolol—Dermatitis—Dorzolamide—glaucoma	3.12e-05	0.000463	CcSEcCtD
Acebutolol—Rash—Travoprost—glaucoma	3.11e-05	0.000462	CcSEcCtD
Acebutolol—Dermatitis—Travoprost—glaucoma	3.11e-05	0.000461	CcSEcCtD
Acebutolol—Headache—Dorzolamide—glaucoma	3.11e-05	0.000461	CcSEcCtD
Acebutolol—Anorexia—Betaxolol—glaucoma	3.11e-05	0.000461	CcSEcCtD
Acebutolol—Vomiting—Brinzolamide—glaucoma	3.1e-05	0.00046	CcSEcCtD
Acebutolol—Dizziness—Pilocarpine—glaucoma	3.1e-05	0.00046	CcSEcCtD
Acebutolol—Headache—Travoprost—glaucoma	3.09e-05	0.000459	CcSEcCtD
Acebutolol—Nausea—Brimonidine—glaucoma	3.08e-05	0.000458	CcSEcCtD
Acebutolol—Feeling abnormal—Clonidine—glaucoma	3.08e-05	0.000457	CcSEcCtD
Acebutolol—Rash—Brinzolamide—glaucoma	3.07e-05	0.000456	CcSEcCtD
Acebutolol—Vision blurred—Timolol—glaucoma	3.07e-05	0.000456	CcSEcCtD
Acebutolol—Dermatitis—Brinzolamide—glaucoma	3.07e-05	0.000456	CcSEcCtD
Acebutolol—Gastrointestinal pain—Clonidine—glaucoma	3.06e-05	0.000454	CcSEcCtD
Acebutolol—Headache—Brinzolamide—glaucoma	3.05e-05	0.000453	CcSEcCtD
Acebutolol—Hypotension—Betaxolol—glaucoma	3.04e-05	0.000452	CcSEcCtD
Acebutolol—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	3.03e-05	0.0464	CbGpPWpGaD
Acebutolol—Vomiting—Pilocarpine—glaucoma	2.98e-05	0.000442	CcSEcCtD
Acebutolol—Urticaria—Clonidine—glaucoma	2.97e-05	0.000441	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Betaxolol—glaucoma	2.97e-05	0.00044	CcSEcCtD
Acebutolol—Abdominal pain—Clonidine—glaucoma	2.96e-05	0.000439	CcSEcCtD
Acebutolol—Body temperature increased—Clonidine—glaucoma	2.96e-05	0.000439	CcSEcCtD
Acebutolol—Rash—Pilocarpine—glaucoma	2.95e-05	0.000438	CcSEcCtD
Acebutolol—Dermatitis—Pilocarpine—glaucoma	2.95e-05	0.000438	CcSEcCtD
Acebutolol—Insomnia—Betaxolol—glaucoma	2.95e-05	0.000437	CcSEcCtD
Acebutolol—Nausea—Dorzolamide—glaucoma	2.95e-05	0.000437	CcSEcCtD
Acebutolol—Headache—Pilocarpine—glaucoma	2.94e-05	0.000435	CcSEcCtD
Acebutolol—Nausea—Travoprost—glaucoma	2.93e-05	0.000435	CcSEcCtD
Acebutolol—Vertigo—Timolol—glaucoma	2.93e-05	0.000435	CcSEcCtD
Acebutolol—Paraesthesia—Betaxolol—glaucoma	2.93e-05	0.000434	CcSEcCtD
Acebutolol—Syncope—Timolol—glaucoma	2.92e-05	0.000434	CcSEcCtD
Acebutolol—Dyspnoea—Betaxolol—glaucoma	2.9e-05	0.000431	CcSEcCtD
Acebutolol—Nausea—Brinzolamide—glaucoma	2.9e-05	0.00043	CcSEcCtD
Acebutolol—Palpitations—Timolol—glaucoma	2.88e-05	0.000427	CcSEcCtD
Acebutolol—ADRB1—Endothelin Pathways—MYLK—glaucoma	2.87e-05	0.044	CbGpPWpGaD
Acebutolol—Dyspepsia—Betaxolol—glaucoma	2.87e-05	0.000425	CcSEcCtD
Acebutolol—Loss of consciousness—Timolol—glaucoma	2.87e-05	0.000425	CcSEcCtD
Acebutolol—Cough—Timolol—glaucoma	2.85e-05	0.000422	CcSEcCtD
Acebutolol—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	2.85e-05	0.0436	CbGpPWpGaD
Acebutolol—Decreased appetite—Betaxolol—glaucoma	2.83e-05	0.00042	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Betaxolol—glaucoma	2.81e-05	0.000417	CcSEcCtD
Acebutolol—Fatigue—Betaxolol—glaucoma	2.81e-05	0.000417	CcSEcCtD
Acebutolol—Constipation—Betaxolol—glaucoma	2.79e-05	0.000413	CcSEcCtD
Acebutolol—Pain—Betaxolol—glaucoma	2.79e-05	0.000413	CcSEcCtD
Acebutolol—Nausea—Pilocarpine—glaucoma	2.78e-05	0.000413	CcSEcCtD
Acebutolol—Arthralgia—Timolol—glaucoma	2.78e-05	0.000412	CcSEcCtD
Acebutolol—Myalgia—Timolol—glaucoma	2.78e-05	0.000412	CcSEcCtD
Acebutolol—Chest pain—Timolol—glaucoma	2.78e-05	0.000412	CcSEcCtD
Acebutolol—Anxiety—Timolol—glaucoma	2.77e-05	0.00041	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	2.76e-05	0.000409	CcSEcCtD
Acebutolol—Discomfort—Timolol—glaucoma	2.74e-05	0.000407	CcSEcCtD
Acebutolol—SLC22A1—Amine compound SLC transporters—SLC6A13—glaucoma	2.7e-05	0.0413	CbGpPWpGaD
Acebutolol—Asthenia—Clonidine—glaucoma	2.69e-05	0.000398	CcSEcCtD
Acebutolol—Feeling abnormal—Betaxolol—glaucoma	2.68e-05	0.000398	CcSEcCtD
Acebutolol—Confusional state—Timolol—glaucoma	2.68e-05	0.000398	CcSEcCtD
Acebutolol—Oedema—Timolol—glaucoma	2.66e-05	0.000395	CcSEcCtD
Acebutolol—Pruritus—Clonidine—glaucoma	2.65e-05	0.000393	CcSEcCtD
Acebutolol—Shock—Timolol—glaucoma	2.62e-05	0.000388	CcSEcCtD
Acebutolol—Nervous system disorder—Timolol—glaucoma	2.61e-05	0.000387	CcSEcCtD
Acebutolol—Urticaria—Betaxolol—glaucoma	2.59e-05	0.000384	CcSEcCtD
Acebutolol—Skin disorder—Timolol—glaucoma	2.59e-05	0.000383	CcSEcCtD
Acebutolol—Body temperature increased—Betaxolol—glaucoma	2.58e-05	0.000382	CcSEcCtD
Acebutolol—Hyperhidrosis—Timolol—glaucoma	2.57e-05	0.000382	CcSEcCtD
Acebutolol—Diarrhoea—Clonidine—glaucoma	2.56e-05	0.00038	CcSEcCtD
Acebutolol—Anorexia—Timolol—glaucoma	2.54e-05	0.000376	CcSEcCtD
Acebutolol—Hypotension—Timolol—glaucoma	2.49e-05	0.000369	CcSEcCtD
Acebutolol—Dizziness—Clonidine—glaucoma	2.47e-05	0.000367	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Timolol—glaucoma	2.42e-05	0.00036	CcSEcCtD
Acebutolol—Insomnia—Timolol—glaucoma	2.41e-05	0.000357	CcSEcCtD
Acebutolol—Paraesthesia—Timolol—glaucoma	2.39e-05	0.000355	CcSEcCtD
Acebutolol—Vomiting—Clonidine—glaucoma	2.38e-05	0.000353	CcSEcCtD
Acebutolol—Dyspnoea—Timolol—glaucoma	2.37e-05	0.000352	CcSEcCtD
Acebutolol—Somnolence—Timolol—glaucoma	2.37e-05	0.000351	CcSEcCtD
Acebutolol—Rash—Clonidine—glaucoma	2.36e-05	0.00035	CcSEcCtD
Acebutolol—Dermatitis—Clonidine—glaucoma	2.36e-05	0.00035	CcSEcCtD
Acebutolol—Headache—Clonidine—glaucoma	2.34e-05	0.000348	CcSEcCtD
Acebutolol—Dyspepsia—Timolol—glaucoma	2.34e-05	0.000348	CcSEcCtD
Acebutolol—Asthenia—Betaxolol—glaucoma	2.34e-05	0.000347	CcSEcCtD
Acebutolol—Decreased appetite—Timolol—glaucoma	2.31e-05	0.000343	CcSEcCtD
Acebutolol—Pruritus—Betaxolol—glaucoma	2.31e-05	0.000342	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Timolol—glaucoma	2.3e-05	0.000341	CcSEcCtD
Acebutolol—Fatigue—Timolol—glaucoma	2.29e-05	0.00034	CcSEcCtD
Acebutolol—Pain—Timolol—glaucoma	2.28e-05	0.000338	CcSEcCtD
Acebutolol—Diarrhoea—Betaxolol—glaucoma	2.23e-05	0.000331	CcSEcCtD
Acebutolol—Nausea—Clonidine—glaucoma	2.22e-05	0.00033	CcSEcCtD
Acebutolol—Feeling abnormal—Timolol—glaucoma	2.19e-05	0.000325	CcSEcCtD
Acebutolol—Gastrointestinal pain—Timolol—glaucoma	2.18e-05	0.000323	CcSEcCtD
Acebutolol—Dizziness—Betaxolol—glaucoma	2.15e-05	0.00032	CcSEcCtD
Acebutolol—Urticaria—Timolol—glaucoma	2.11e-05	0.000314	CcSEcCtD
Acebutolol—Body temperature increased—Timolol—glaucoma	2.1e-05	0.000312	CcSEcCtD
Acebutolol—Abdominal pain—Timolol—glaucoma	2.1e-05	0.000312	CcSEcCtD
Acebutolol—Vomiting—Betaxolol—glaucoma	2.07e-05	0.000307	CcSEcCtD
Acebutolol—SLC22A1—Neurotransmitter Release Cycle—SLC6A13—glaucoma	2.06e-05	0.0316	CbGpPWpGaD
Acebutolol—Rash—Betaxolol—glaucoma	2.05e-05	0.000305	CcSEcCtD
Acebutolol—Dermatitis—Betaxolol—glaucoma	2.05e-05	0.000304	CcSEcCtD
Acebutolol—Headache—Betaxolol—glaucoma	2.04e-05	0.000303	CcSEcCtD
Acebutolol—SLC22A1—Amine compound SLC transporters—SLC6A1—glaucoma	1.97e-05	0.0302	CbGpPWpGaD
Acebutolol—Nausea—Betaxolol—glaucoma	1.94e-05	0.000287	CcSEcCtD
Acebutolol—Asthenia—Timolol—glaucoma	1.91e-05	0.000283	CcSEcCtD
Acebutolol—Pruritus—Timolol—glaucoma	1.88e-05	0.000279	CcSEcCtD
Acebutolol—Diarrhoea—Timolol—glaucoma	1.82e-05	0.00027	CcSEcCtD
Acebutolol—Dizziness—Timolol—glaucoma	1.76e-05	0.000261	CcSEcCtD
Acebutolol—Vomiting—Timolol—glaucoma	1.69e-05	0.000251	CcSEcCtD
Acebutolol—Rash—Timolol—glaucoma	1.68e-05	0.000249	CcSEcCtD
Acebutolol—Dermatitis—Timolol—glaucoma	1.68e-05	0.000249	CcSEcCtD
Acebutolol—Headache—Timolol—glaucoma	1.67e-05	0.000247	CcSEcCtD
Acebutolol—ADRB1—Melatonin metabolism and effects—CYP1B1—glaucoma	1.59e-05	0.0243	CbGpPWpGaD
Acebutolol—Nausea—Timolol—glaucoma	1.58e-05	0.000235	CcSEcCtD
Acebutolol—ADRB2—GPCRs, Other—PTGFR—glaucoma	1.51e-05	0.0231	CbGpPWpGaD
Acebutolol—SLC22A1—Neurotransmitter Release Cycle—SLC6A1—glaucoma	1.51e-05	0.0231	CbGpPWpGaD
Acebutolol—ADRB1—Melatonin metabolism and effects—EDN1—glaucoma	1.28e-05	0.0196	CbGpPWpGaD
Acebutolol—ADRB1—Endothelin Pathways—EDN1—glaucoma	1.16e-05	0.0177	CbGpPWpGaD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	1.05e-05	0.0162	CbGpPWpGaD
Acebutolol—ADRB1—Melatonin metabolism and effects—APOE—glaucoma	1.04e-05	0.016	CbGpPWpGaD
Acebutolol—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	1.01e-05	0.0154	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	8.15e-06	0.0125	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	7.98e-06	0.0122	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	7.97e-06	0.0122	CbGpPWpGaD
Acebutolol—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	7.77e-06	0.0119	CbGpPWpGaD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	7.72e-06	0.0118	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—SMO—glaucoma	7.62e-06	0.0117	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	7.45e-06	0.0114	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	7.29e-06	0.0112	CbGpPWpGaD
Acebutolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	7.26e-06	0.0111	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	7.18e-06	0.011	CbGpPWpGaD
Acebutolol—ADRB1—Endothelin Pathways—NOS3—glaucoma	7.05e-06	0.0108	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	6.71e-06	0.0103	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	6.57e-06	0.0101	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	6.39e-06	0.00978	CbGpPWpGaD
Acebutolol—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	6.28e-06	0.00962	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	6.25e-06	0.00957	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—SLC6A13—glaucoma	5.91e-06	0.00906	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	5.75e-06	0.00881	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	5.63e-06	0.00862	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—PEX19—glaucoma	5.41e-06	0.00828	CbGpPWpGaD
Acebutolol—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	5.11e-06	0.00782	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—OPN4—glaucoma	4.86e-06	0.00745	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	4.79e-06	0.00734	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—OPN4—glaucoma	4.76e-06	0.00729	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—SLC6A13—glaucoma	4.53e-06	0.00694	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—PTGFR—glaucoma	4.38e-06	0.00671	CbGpPWpGaD
Acebutolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.34e-06	0.00665	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—SLC6A1—glaucoma	4.33e-06	0.00663	CbGpPWpGaD
Acebutolol—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.28e-06	0.00656	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—PTGFR—glaucoma	4.28e-06	0.00656	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	3.65e-06	0.00559	CbGpPWpGaD
Acebutolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.52e-06	0.00539	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	3.51e-06	0.00537	CbGpPWpGaD
Acebutolol—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	3.45e-06	0.00529	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—SLC6A1—glaucoma	3.32e-06	0.00508	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	3.17e-06	0.00485	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—NARFL—glaucoma	2.98e-06	0.00456	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CA5A—glaucoma	2.98e-06	0.00456	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL1A—glaucoma	2.97e-06	0.00455	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—OPN4—glaucoma	2.75e-06	0.00421	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—OPN4—glaucoma	2.69e-06	0.00412	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—FAS—glaucoma	2.65e-06	0.00406	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—C3—glaucoma	2.61e-06	0.004	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—OPN4—glaucoma	2.5e-06	0.00382	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PTGFR—glaucoma	2.47e-06	0.00379	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—OPN4—glaucoma	2.44e-06	0.00374	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.44e-06	0.00373	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PTGFR—glaucoma	2.42e-06	0.00371	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—GSTT1—glaucoma	2.35e-06	0.00359	CbGpPWpGaD
Acebutolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	2.31e-06	0.00354	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PTGFR—glaucoma	2.25e-06	0.00344	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	2.24e-06	0.00343	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—SMO—glaucoma	2.21e-06	0.00338	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PTGFR—glaucoma	2.2e-06	0.00337	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—SMO—glaucoma	2.16e-06	0.00331	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	2.14e-06	0.00328	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LRP12—glaucoma	2.13e-06	0.00326	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LRP12—glaucoma	2.08e-06	0.00319	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.91e-06	0.00293	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.87e-06	0.00286	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—CYP1B1—glaucoma	1.87e-06	0.00286	CbGpPWpGaD
Acebutolol—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	1.84e-06	0.00282	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.78e-06	0.00273	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CA5A—glaucoma	1.75e-06	0.00267	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NARFL—glaucoma	1.75e-06	0.00267	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.67e-06	0.00256	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	1.67e-06	0.00256	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NARFL—glaucoma	1.64e-06	0.00252	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CA5A—glaucoma	1.64e-06	0.00252	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.63e-06	0.0025	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	1.54e-06	0.00236	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	1.53e-06	0.00234	CbGpPWpGaD
Acebutolol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	1.52e-06	0.00232	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—GSTM1—glaucoma	1.49e-06	0.00229	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—OPN4—glaucoma	1.47e-06	0.00226	CbGpPWpGaD
Acebutolol—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	1.47e-06	0.00226	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—EDN1—glaucoma	1.46e-06	0.00223	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CA1—glaucoma	1.45e-06	0.00223	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—OPN4—glaucoma	1.44e-06	0.00221	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.43e-06	0.00219	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—EDN1—glaucoma	1.42e-06	0.00218	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CTSA—glaucoma	1.41e-06	0.00216	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HEYL—glaucoma	1.37e-06	0.0021	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HEYL—glaucoma	1.34e-06	0.00205	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CA2—glaucoma	1.33e-06	0.00204	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTGFR—glaucoma	1.33e-06	0.00203	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—VEGFA—glaucoma	1.31e-06	0.00201	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.31e-06	0.002	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTGFR—glaucoma	1.3e-06	0.00199	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—C3—glaucoma	1.27e-06	0.00195	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—C3—glaucoma	1.24e-06	0.00191	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—SMO—glaucoma	1.13e-06	0.00174	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—TNF—glaucoma	1.12e-06	0.00172	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.12e-06	0.00171	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—SMO—glaucoma	1.11e-06	0.0017	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.05e-06	0.0016	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RPTOR—glaucoma	1.04e-06	0.00159	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RPTOR—glaucoma	1.02e-06	0.00156	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NCK2—glaucoma	1.01e-06	0.00154	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NCK2—glaucoma	9.84e-07	0.00151	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—TXN—glaucoma	9.37e-07	0.00144	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HDAC9—glaucoma	8.55e-07	0.00131	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CA1—glaucoma	8.52e-07	0.00131	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HDAC9—glaucoma	8.37e-07	0.00128	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CTSA—glaucoma	8.25e-07	0.00126	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—EDN1—glaucoma	8.23e-07	0.00126	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	8.22e-07	0.00126	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—EDN1—glaucoma	8.05e-07	0.00123	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CA1—glaucoma	8.03e-07	0.00123	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CA2—glaucoma	7.79e-07	0.00119	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.79e-07	0.00119	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CTSA—glaucoma	7.78e-07	0.00119	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EDN1—glaucoma	7.47e-07	0.00114	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CA2—glaucoma	7.35e-07	0.00112	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EDN1—glaucoma	7.31e-07	0.00112	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTT1—glaucoma	7.26e-07	0.00111	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—C3—glaucoma	7.19e-07	0.0011	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—C3—glaucoma	7.03e-07	0.00108	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SMO—glaucoma	6.69e-07	0.00103	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SMO—glaucoma	6.55e-07	0.001	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—C3—glaucoma	6.53e-07	0.001	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.48e-07	0.000992	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—C3—glaucoma	6.38e-07	0.000978	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NTRK2—glaucoma	6.12e-07	0.000938	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NTRK2—glaucoma	5.99e-07	0.000917	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ABCA1—glaucoma	5.79e-07	0.000887	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP1B1—glaucoma	5.79e-07	0.000887	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.55e-07	0.00085	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TXN—glaucoma	5.49e-07	0.000841	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NGFR—glaucoma	5.25e-07	0.000805	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TXN—glaucoma	5.18e-07	0.000793	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NGFR—glaucoma	5.14e-07	0.000787	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NTRK1—glaucoma	4.99e-07	0.000764	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.89e-07	0.00075	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NTRK1—glaucoma	4.88e-07	0.000748	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTM1—glaucoma	4.63e-07	0.000709	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN2B—glaucoma	4.6e-07	0.000704	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN2B—glaucoma	4.5e-07	0.000689	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EDN1—glaucoma	4.41e-07	0.000676	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EDN1—glaucoma	4.32e-07	0.000661	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTT1—glaucoma	4.26e-07	0.000652	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MTHFR—glaucoma	4.09e-07	0.000626	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NGF—glaucoma	4.06e-07	0.000621	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTT1—glaucoma	4.01e-07	0.000615	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NGF—glaucoma	3.97e-07	0.000608	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—C3—glaucoma	3.86e-07	0.000591	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOE—glaucoma	3.81e-07	0.000583	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CAV1—glaucoma	3.77e-07	0.000578	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—C3—glaucoma	3.77e-07	0.000578	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOE—glaucoma	3.59e-07	0.00055	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CAV1—glaucoma	3.56e-07	0.000545	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOE—glaucoma	3.51e-07	0.000538	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CAV1—glaucoma	3.48e-07	0.000533	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP1B1—glaucoma	3.39e-07	0.00052	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ABCA1—glaucoma	3.39e-07	0.00052	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FN1—glaucoma	3.39e-07	0.000518	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BAD—glaucoma	3.34e-07	0.000512	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FN1—glaucoma	3.31e-07	0.000507	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BAD—glaucoma	3.27e-07	0.000501	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP1B1—glaucoma	3.2e-07	0.00049	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCA1—glaucoma	3.2e-07	0.00049	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—NOS3—glaucoma	2.85e-07	0.000437	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTM1—glaucoma	2.71e-07	0.000415	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOS3—glaucoma	2.69e-07	0.000412	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOS3—glaucoma	2.63e-07	0.000403	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—glaucoma	2.61e-07	0.0004	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTM1—glaucoma	2.56e-07	0.000391	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTHFR—glaucoma	2.4e-07	0.000367	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN1B—glaucoma	2.33e-07	0.000357	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN1B—glaucoma	2.28e-07	0.000349	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTHFR—glaucoma	2.26e-07	0.000346	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOE—glaucoma	2.23e-07	0.000342	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CAV1—glaucoma	2.21e-07	0.000339	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—glaucoma	2.16e-07	0.00033	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—glaucoma	2.11e-07	0.000323	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOE—glaucoma	2.1e-07	0.000322	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CAV1—glaucoma	2.08e-07	0.000319	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—glaucoma	1.94e-07	0.000297	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—glaucoma	1.9e-07	0.00029	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NOS3—glaucoma	1.67e-07	0.000256	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NOS3—glaucoma	1.58e-07	0.000241	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—glaucoma	1.53e-07	0.000234	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TP53—glaucoma	1.46e-07	0.000224	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—glaucoma	1.44e-07	0.000221	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TP53—glaucoma	1.43e-07	0.000219	CbGpPWpGaD
